Results of Study on Trisynex Reported at Two Scientific Conferences Demonstrate

May 22, 2007

  • 92% Improvement In Lowering Body Fat
  • 62% Improvement In Reducing Waist Circumference

SAN DIEGO, May 22 /PRNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX - News), announced today that results from the recently completed study at the University of Connecticut on its patented body fat reduction ingredient, Trisynex, were presented at two scientific conferences.

"We are extremely pleased with the results of this study validating the effectiveness of Trisynex in fat loss and body shaping," stated William P. Spencer, President of Imagenetix. "We are most excited as Trisynex is just beginning to be made available to consumers, on a global basis."

Dr. Robert Hesslink, Director, Research & Development at Imagenetix, presented data at the Slimming Ingredient 2007 conference in Berlin, Germany. Dr. Hesslink reviewed the improvements in body composition in subjects consuming Trisynex. Subjects consuming Trisynex experienced a 92% improvement over placebo in lowering body fat and a 62% improvement in reducing waist circumference.

Dr. William Kraemer and staff from the University of Connecticut presented significant clinical data on Trisynex at the Experimental Biology conference in Washington, DC. Experimental Biology is the premiere international scientific conference in the fields of physiology, nutrition, molecular biology and genetics.

The University of Connecticut presented the Trisynex results on the serum adipocytokines and body composition. Subjects consuming Trisynex capsules had a significant reduction in serum leptin and a significant increase in serum adiponectin. These adipocyte hormones are integral biomarkers for healthy body fat storage and utilization.

The reduced serum leptin reflects the lower body fat and waist circumference found in the female subjects. Leptin has been shown to regulate the storage of excess calories and its lowering is vital for reducing body fat, reduction of waist circumference, and the overall management of obesity.

The elevation in serum adiponectin elicited by the consumption of Trisynex is very exciting. Adiponectin has been shown to regulate glucose regulation and balance. In addition, adiponectin is thought to increase fat oxidation within skeletal muscle, which may serve to increase daily caloric expenditure.